Shares of Amgen Inc. AMGN inched 0.08% higher to $278.32 Tuesday, on what proved to be an all-around mixed trading session ...

Patients with recurrent platinum-sensitive ovarian cancer did just as well with cytoreductive surgery alone as they did with ...

Amgen's new obesity drug, MariTide, shows promise against giants Eli Lilly and Novo Nordisk, but faces tough competition in a ...

The donation to Rush’s orthopedic department, the largest ever, creates four new endowed positions and programs.

High-yield bargain opportunities exist for disciplined, value-focused investors. Read more about the two standout stocks I've ...

Following a pair of similar deals in January and June, Coherus BioSciences has netted itself a hefty chunk of change for the ...

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

Congress has targeted pharmacy benefit managers for more than two years, spurring millions spent to influence debates that ...

"This is an exciting time to be joining Tonix as it prepares to receive an FDA decision on its NDA for TNX-102 SL for the ...

Shares of Janux Therapeutics skyrocketed Tuesday on "unprecedented" results for an experimental prostate cancer treatment.

Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05 ...

German biotech asks federal judge to reject Amgen’s efforts to narrow scope of a key patent in ongoing dispute | Patent ...